Logo image of AMRZ

AMRIZE LTD (AMRZ) Stock Fundamental Analysis

USA - NYSE:AMRZ - CH1430134226 - Common Stock

47.13 USD
-1.21 (-2.5%)
Last: 10/7/2025, 8:09:30 PM
47.24 USD
+0.11 (+0.23%)
After Hours: 10/7/2025, 8:09:30 PM
Fundamental Rating

2

Overall AMRZ gets a fundamental rating of 2 out of 10. We evaluated AMRZ against 13 industry peers in the Construction Materials industry. AMRZ may be in some trouble as it scores bad on both profitability and health. AMRZ has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

AMRZ had positive earnings in the past year.
AMRZ Yearly Net Income VS EBIT VS OCF VS FCFAMRZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

AMRZ has a Return On Assets (5.36%) which is in line with its industry peers.
With a Return On Equity value of 10.25%, AMRZ is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
AMRZ has a Return On Invested Capital of 7.38%. This is comparable to the rest of the industry: AMRZ outperforms 53.85% of its industry peers.
Industry RankSector Rank
ROA 5.36%
ROE 10.25%
ROIC 7.38%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMRZ Yearly ROA, ROE, ROICAMRZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a decent Profit Margin value of 10.89%, AMRZ is doing good in the industry, outperforming 61.54% of the companies in the same industry.
AMRZ's Operating Margin of 18.16% is fine compared to the rest of the industry. AMRZ outperforms 61.54% of its industry peers.
With a Gross Margin value of 26.23%, AMRZ is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
Industry RankSector Rank
OM 18.16%
PM (TTM) 10.89%
GM 26.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMRZ Yearly Profit, Operating, Gross MarginsAMRZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15 20 25

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMRZ is still creating some value.
The number of shares outstanding for AMRZ remains at a similar level compared to 1 year ago.
Compared to 1 year ago, AMRZ has an improved debt to assets ratio.
AMRZ Yearly Shares OutstandingAMRZ Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 100M 200M 300M 400M 500M
AMRZ Yearly Total Debt VS Total AssetsAMRZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 2.26 indicates that AMRZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
AMRZ's Altman-Z score of 2.26 is on the low side compared to the rest of the industry. AMRZ is outperformed by 61.54% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that AMRZ is somewhat dependend on debt financing.
AMRZ has a Debt to Equity ratio (0.52) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 2.26
ROIC/WACC1.45
WACC5.09%
AMRZ Yearly LT Debt VS Equity VS FCFAMRZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

AMRZ has a Current Ratio of 1.38. This is a normal value and indicates that AMRZ is financially healthy and should not expect problems in meeting its short term obligations.
AMRZ's Current ratio of 1.38 is on the low side compared to the rest of the industry. AMRZ is outperformed by 69.23% of its industry peers.
A Quick Ratio of 0.85 indicates that AMRZ may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.85, AMRZ is doing worse than 69.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.85
AMRZ Yearly Current Assets VS Current LiabilitesAMRZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

AMRZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.26%, which is quite impressive.
The Revenue has been growing slightly by 0.23% in the past year.
EPS 1Y (TTM)33.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.5%
Revenue 1Y (TTM)0.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.71%

3.2 Future

Based on estimates for the next years, AMRZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.80% on average per year.
The Revenue is expected to grow by 4.97% on average over the next years.
EPS Next Y11.77%
EPS Next 2Y13.28%
EPS Next 3Y13.8%
EPS Next 5YN/A
Revenue Next Year3.12%
Revenue Next 2Y4.28%
Revenue Next 3Y4.97%
Revenue Next 5YN/A

3.3 Evolution

AMRZ Yearly Revenue VS EstimatesAMRZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
AMRZ Yearly EPS VS EstimatesAMRZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.49, which indicates a rather expensive current valuation of AMRZ.
61.54% of the companies in the same industry are more expensive than AMRZ, based on the Price/Earnings ratio.
AMRZ is valuated rather cheaply when we compare the Price/Earnings ratio to 27.76, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 15.93, which indicates a correct valuation of AMRZ.
76.92% of the companies in the same industry are more expensive than AMRZ, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of AMRZ to the average of the S&P500 Index (23.21), we can say AMRZ is valued slightly cheaper.
Industry RankSector Rank
PE 20.49
Fwd PE 15.93
AMRZ Price Earnings VS Forward Price EarningsAMRZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

AMRZ's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AMRZ is cheaper than 76.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.54
AMRZ Per share dataAMRZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

AMRZ's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
AMRZ's earnings are expected to grow with 13.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.74
PEG (5Y)N/A
EPS Next 2Y13.28%
EPS Next 3Y13.8%

More info and screens

0

5. Dividend

5.1 Amount

AMRZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMRIZE LTD

NYSE:AMRZ (10/7/2025, 8:09:30 PM)

After market: 47.24 +0.11 (+0.23%)

47.13

-1.21 (-2.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)10-29 2025-10-29
Inst Owners37.75%
Inst Owner ChangeN/A
Ins Owners7.13%
Ins Owner Change-34591.7%
Market Cap26.07B
Analysts80
Price TargetN/A
Short Float %1.07%
Short Ratio1.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-8.19%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.15%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.49
Fwd PE 15.93
P/S 2.23
P/FCF N/A
P/OCF N/A
P/B 2.1
P/tB 16.21
EV/EBITDA 10.54
EPS(TTM)2.3
EY4.88%
EPS(NY)2.96
Fwd EY6.28%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS21.16
BVpS22.48
TBVpS2.91
PEG (NY)1.74
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.36%
ROE 10.25%
ROCE 10.3%
ROIC 7.38%
ROICexc 7.59%
ROICexgc 15.69%
OM 18.16%
PM (TTM) 10.89%
GM 26.23%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA 2.15
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.85
Altman-Z 2.26
F-ScoreN/A
WACC5.09%
ROIC/WACC1.45
Cap/Depr(3y)69.39%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.14%
Cap/Sales(5y)N/A
Profit Quality(3y)137.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.5%
EPS Next Y11.77%
EPS Next 2Y13.28%
EPS Next 3Y13.8%
EPS Next 5YN/A
Revenue 1Y (TTM)0.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.71%
Revenue Next Year3.12%
Revenue Next 2Y4.28%
Revenue Next 3Y4.97%
Revenue Next 5YN/A
EBIT growth 1Y13.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.27%
EBIT Next 3Y20.21%
EBIT Next 5YN/A
FCF growth 1Y16.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.08%
OCF growth 3YN/A
OCF growth 5YN/A